A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.25 EUR Market Closed
Market Cap: 3.9m EUR

Intrinsic Value

ALACT's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one ALACT stock under the Base Case scenario is 30.74 EUR. Compared to the current market price of 0.25 EUR, Acticor Biotech SA is Undervalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALACT Intrinsic Value
30.74 EUR
Undervaluation 99%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ALACT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Acticor Biotech SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Acticor Biotech SA

Current Assets 9.3m
Cash & Short-Term Investments 3.9m
Receivables 4.4m
Other Current Assets 986k
Non-Current Assets 461k
Long-Term Investments 439k
PP&E 22k
Efficiency

Free Cash Flow Analysis
Acticor Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Acticor Biotech SA

Revenue
0 EUR
Operating Expenses
-17.6m EUR
Operating Income
-17.6m EUR
Other Expenses
-1.1m EUR
Net Income
-18.6m EUR
Fundamental Scores

ALACT Profitability Score
Profitability Due Diligence

Acticor Biotech SA's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

43/100
Profitability
Score

Acticor Biotech SA's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

ALACT Solvency Score
Solvency Due Diligence

Acticor Biotech SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
45/100
Solvency
Score

Acticor Biotech SA's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALACT Price Targets Summary
Acticor Biotech SA

There are no price targets for ALACT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Acticor Biotech SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALACT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y